Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis.
about
The role of common protective alleles HLA-DRB1*13 among systemic autoimmune diseases.The MHC locus and genetic susceptibility to autoimmune and infectious diseases.The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases.Immune responses to Mycobacterial heat shock protein 70 accompany self-reactivity to human BiP in rheumatoid arthritisAssociations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism.Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis.Pre-symptomatic autoimmunity in rheumatoid arthritis: when does the disease start?Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy?A reciprocal HLA-Disease Association in Rheumatoid Arthritis and Pemphigus Vulgaris.HLA class II and rheumatoid arthritis: the bumpy road of revelation.Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA.Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features.The increased ability to present citrullinated peptides is not unique to HLA-SE molecules: arginine-to-citrulline conversion also enhances peptide affinity for HLA-DQ molecules.Human MHC-II with Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands-Relation to Rheumatoid Arthritis.High-sensitivity virus and mycoplasma screening test reveals high prevalence of parvovirus B19 infection in human synovial tissues and bone marrow.
P2860
Q30241539-234049BC-07EF-41D5-B579-FB2987A53063Q33608703-D6439678-B86D-4D4B-B313-6361C1EFC694Q36271927-7D30404B-FB7D-4FF6-94E4-D1F0DECDA8F6Q36634809-85DFE4CC-B977-47DF-BD80-9F43B57027ABQ38569872-A71667E5-5C47-4255-8EC2-C350777EE552Q38657171-67A4F0F6-D6E0-4314-9615-E49C19E60844Q38880624-47DE33AD-6B36-4874-B608-C59A7F2B9770Q38957340-36EC6A95-6CE4-4D1A-9F99-E66490D3E417Q38998954-83381185-C621-45D1-94E1-1732FC62D92CQ39427587-D3134E08-F9B7-4675-B7DA-4D708E793860Q40160018-429EC30A-9739-4BD7-B14E-0183A5140F2AQ41563600-8A51C8D7-8E2B-45D6-A060-2D8E82F90CFBQ41661241-7A41EDBC-0155-4BAB-9BFB-6014BE3F10F2Q47549698-E0C6CC7C-94BB-40BA-8AE2-0A911BF919D6Q55193404-B1589CFE-D709-42CA-B8FF-95A2B3041C9B
P2860
Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Crossreactivity to vinculin an ...... against rheumatoid arthritis.
@en
type
label
Crossreactivity to vinculin an ...... against rheumatoid arthritis.
@en
prefLabel
Crossreactivity to vinculin an ...... against rheumatoid arthritis.
@en
P2093
P2860
P50
P356
P1476
Crossreactivity to vinculin an ...... against rheumatoid arthritis.
@en
P2093
Anouk L Feitsma
Antonis K Moustakas
Diahann T S L Jansen
Diënne G Bontrop-Elferink
Frits Koning
Georgios Archontis
Jurgen van Heemst
Marieke Bax
Martine Baarse
René R P de Vries
P2860
P2888
P356
10.1038/NCOMMS7681
P407
P577
2015-05-05T00:00:00Z
P5875
P6179
1015450996